Your browser doesn't support javascript.
loading
Use of hydrochlorothiazide in Denmark following publication of skin cancer risk findings.
Pottegård, Anton; Bech, Bodil Hammer; Pedersen, Sidsel Arnspang; Christensen, Bo.
Affiliation
  • Pottegård A; Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
  • Bech BH; Research Unit for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Pedersen SA; Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
  • Christensen B; Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.
Pharmacoepidemiol Drug Saf ; 30(11): 1611-1616, 2021 11.
Article in En | MEDLINE | ID: mdl-34435407
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Hydrochlorothiazide Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Denmark
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Hydrochlorothiazide Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Denmark